MITCHELL CHAN plan to sell securities of AVALO THERAPEUTICS, INC. under Form 144
2026-05-06SEC Filing 144 (0001950047-26-004138)
MITCHELL CHAN filed Form 144 to notify SEC of plan to sell 3167 units of AVALO THERAPEUTICS, INC. securities around 2026-05-06, with aggregate market value of $51,495.42. The total outstanding units is 22788452.0. The amount planned to be sold represents 0.01% of total outstanding units;